You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Details for New Drug Application (NDA): 218175

✉ Email this page to a colleague

« Back to Dashboard

NDA 218175 describes MINOXIDIL (FOR WOMEN), which is a drug marketed by Aurobindo Pharma, P And L, Taro, Apotex Inc, Aurobindo Pharma Ltd, Hikma, L Perrigo Co, and Sight Pharms, and is included in nine NDAs. It is available from thirty-four suppliers. Additional details are available on the MINOXIDIL (FOR WOMEN) profile page.

The generic ingredient in MINOXIDIL (FOR WOMEN) is minoxidil. There are eight drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the minoxidil profile page.

Summary for 218175

Tradename:	MINOXIDIL (FOR WOMEN)
Applicant:	Taro
Ingredient:	minoxidil
Patents:	0

Pharmacology for NDA: 218175

Physiological Effect	Arteriolar Vasodilation

Medical Subject Heading (MeSH) Categories for 218175

Antihypertensive Agents
Vasodilator Agents

Suppliers and Packaging for NDA: 218175

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
MINOXIDIL (FOR WOMEN)	minoxidil	SOLUTION;TOPICAL	218175	ANDA	SUN PHARMACEUTICAL INDUSTRIES, INC.	51672-2152	51672-2152-4	1 BOTTLE in 1 CARTON (51672-2152-4) / 60 mL in 1 BOTTLE
MINOXIDIL (FOR WOMEN)	minoxidil	SOLUTION;TOPICAL	218175	ANDA	SUN PHARMACEUTICAL INDUSTRIES, INC.	51672-2152	51672-2152-9	3 BOTTLE in 1 CARTON (51672-2152-9) / 60 mL in 1 BOTTLE

Profile for product number 001

Active Rx/OTC/Discontinued:	OTC	Dosage:	SOLUTION;TOPICAL			Strength	2%
Approval Date:	Nov 26, 2024	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.